HONG KONG—Veteran bowler David Tso is on course for his first national trophy since 1998, after defeating a strong Youth Development team in the semi-finals of the National Fours last Sunday, March 1.
Merck’s reinvigorated pipeline and Sanofi’s minimal patent-loss exposure placed them atop our rankings this year, while GlaxoSmithKline joined Pfizer toward the bottom.
A British private investigator and his Chinese-American wife are being prosecuted in Shanghai, ostensibly for obtaining private information of Chinese citizens.
HONG KONG—Veteran bowler David Tso is on course for his first national trophy since 1998, after defeating a strong Youth Development team in the semi-finals of the National Fours last Sunday, March 1.
Merck’s reinvigorated pipeline and Sanofi’s minimal patent-loss exposure placed them atop our rankings this year, while GlaxoSmithKline joined Pfizer toward the bottom.
A British private investigator and his Chinese-American wife are being prosecuted in Shanghai, ostensibly for obtaining private information of Chinese citizens.